CANTA.ST Net Margin

The Net Margin of Cantargia AB (CANTA.ST) is 46.41%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

CANTA.ST Net Margin - Historical Value

Date	Value
2025-12-31	46.41%

CANTA.ST Net Margin - Peers Comparison

Ticker	Name	Value
SNG.L	Synairgen PLC	-3143.81%
KDS.AS	Kiadis Pharma NV	-468.23%
OSE.PA	OSE Immunotherapeutics SA	44.88%
SOBI.ST	Swedish Orphan Biovitrum AB (publ)	1.69%
XBRANE.ST	Xbrane Biopharma AB	83.52%
TILS.L	Tiziana Life Sciences PLC	-589.47%
FARN.L	Faron Pharmaceuticals Oy	-105715.80%
HPHA.DE	Heidelberg Pharma AG	-282.98%
NANO.PA	Nanobiotix SA	586.89%
ORPHA.CO	Orphazyme A/S	-1731.11%
BIOA B.ST	BioArctic AB	51.14%
BIOG B.ST	Biogaia AB	21.63%
ORY.MC	Oryzon Genomics SA	-26000.00%
SANION.ST	Saniona AB	65.53%
ABVX.PA	Abivax SA	-50800.00%
BINV.ST	BioInvent International AB	-146.96%
HNSA.ST	Hansa Biopharma AB	-238.12%
ALQGC.PA	Quantum Genomics SA	-31520.38%
DMYD B.ST	Diamyd Medical AB	-130597.69%
SCLP.L	Scancell Holdings PLC	-260.50%
SIGHT.PA	Gensight Biologics SA	-933.40%
IVACC.ST	Intervacc AB	-402.32%
MAB.WA	Mabion SA	-9.18%
PROB.ST	Probi AB	2.68%
BGBIO.OL	Bergenbio ASA	-16424.76%
BONEX.ST	Bonesupport Holding AB	12.10%
BVXP.L	Bioventix PLC	57.83%
IVA.PA	Inventiva SA	-2002.75%
VITR.ST	Vitrolife AB	-145.73%
AEGIR.ST	Aegirbio AB	-64886.96%
NANOV.OL	Nordic Nanovector ASA	-97289.40%
POXEL.PA	Poxel SA	-275.84%
VVY.AS	Vivoryon Therapeutics NV	-117.57%
XSPRAY.ST	XSpray Pharma AB (publ)	-8338.63%